Neurological disorders are becoming a growing burden as society ages, and there is a
compelling need to address this spiraling problem. Stem cell‐based regenerative medicine …

Axonal regeneration and formation of tripartite (axo-glial) junctions at damaged sites is a
prerequisite for early repair of injured spinal cord. Transplantation of stem cells at such sites …

Background/Aims: Neurotoxic A1 astrocytes are induced by inflammation after spinal cord
injury (SCI), and the inflammation-related Nuclear Factor Kappa B (NFκB) pathway may be …

In a previous report we showed that intravenous infusion of bone marrow-derived
mesenchymal stem cells (MSCs) improved functional recovery after contusive spinal cord …

Background Although exosomes, as byproducts of human umbilical cord mesenchymal stem
cells (hUC-MSCs), have been demonstrated to be an effective therapy for traumatic spinal …

Spinal Cord Injury (SCI) is a common neurological disorder with devastating psychical and
psychosocial sequelae. The majority of patients after SCI suffer from permanent disability …

Neurodegenerative diseases resulting from the progressive loss of structure and/or function
of neurons contribute to different paralysis degrees and loss of cognition and sensation. The …

Intravenous (IV) infusion of bone marrow‐derived mesenchymal stem/stromal cells (MSCs)
stabilizes the blood‐spinal cord barrier (BSCB) and improves functional recovery in …

Spinal cord injury (SCI) is a traumatic lesion that causes disability with temporary or
permanent sensory and/or motor deficits. The pharmacological approach still in use for the …

The spinal cord is part of the central nervous system (CNS) and serves to connect the brain
to the peripheral nervous system and peripheral tissues. The cell types that primarily …